Neoadjuvant therapy.
作者信息
Niederhuber J E
出版信息
Ann Surg. 1999 Mar;229(3):309-12. doi: 10.1097/00000658-199903000-00002.
Abstract
摘要
相似文献
1
Neoadjuvant therapy.新辅助治疗
Ann Surg. 1999 Mar;229(3):309-12. doi: 10.1097/00000658-199903000-00002.
2
Should induction chemotherapy be considered for all patients with gastric cancer?
Eur J Surg Oncol. 1994 Apr;20(2):185-6.
3
[Neoadjuvant chemotherapy for advanced gastric cancer].
Nihon Rinsho. 2001 Apr;59 Suppl 4:456-62.
4
[Present status of clinical trials of neoadjuvant chemotherapy for gastric cancer and key points in their design].[胃癌新辅助化疗的临床试验现状及其设计要点]
Zhonghua Zhong Liu Za Zhi. 2013 Aug;35(8):636-8.
5
[Neoadjuvant chemotherapy in advanced stomach cancer--a case of complete response].[晚期胃癌的新辅助化疗——一例完全缓解病例]
Magy Seb. 2002 Oct;55(5):321-4.
6
Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer.对新辅助化疗的反应最能预测胃癌根治性切除术后的生存率。
Ann Surg. 1999 Mar;229(3):303-8. doi: 10.1097/00000658-199903000-00001.
7
Multidisciplinary management of gastric cancer.胃癌的多学科综合管理。
Curr Opin Gastroenterol. 2010 Nov;26(6):640-6. doi: 10.1097/MOG.0b013e32833efd9b.
8
Adjuvant and neoadjuvant therapy for gastric cancer.胃癌的辅助治疗和新辅助治疗。
Semin Oncol. 1996 Jun;23(3):379-89.
9
[Adjuvant chemotherapy and chemoradiotherapy of operable gastric cancer: an overview].[可手术胃癌的辅助化疗与放化疗：综述]
Vopr Onkol. 2004;50(5):524-32.
10
[Survival analysis of gastric cancer cases with pathological complete response received neoadjuvant chemotherapy].接受新辅助化疗后达到病理完全缓解的胃癌病例的生存分析
Zhonghua Yi Xue Za Zhi. 2016 May 31;96(20):1582-4. doi: 10.3760/cma.j.issn.0376-2491.2016.20.008.
引用本文的文献
1
PARP Inhibitors in the Neoadjuvant Setting; A Comprehensive Overview of the Rationale for their Use, Past and Ongoing Clinical Trials.新辅助治疗中的PARP抑制剂；其应用原理、既往及正在进行的临床试验的全面概述
Curr Oncol Rep. 2025 May;27(5):533-551. doi: 10.1007/s11912-025-01669-z. Epub 2025 Apr 7.
2
Neoadjuvant VS adjuvant chemotherapy in patients with locally advanced breast cancer; a retrospective cohort study.局部晚期乳腺癌患者新辅助化疗与辅助化疗的比较：一项回顾性队列研究。
Ann Med Surg (Lond). 2022 Nov 15;84:104921. doi: 10.1016/j.amsu.2022.104921. eCollection 2022 Dec.
3
Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.CEA、CA19-9、CA72-4和CA125在接受新辅助化疗的胃癌患者中的临床评估
World J Surg Oncol. 2014 Dec 29;12:397. doi: 10.1186/1477-7819-12-397.
4
Neoadjuvant chemotherapy with a combination of docetaxel, cisplatin, fluorouracil, and leucovorin in nonresectable advanced gastric cancer: a short communication.多西他赛、顺铂、氟尿嘧啶和亚叶酸钙联合新辅助化疗治疗不可切除的晚期胃癌：简短交流。
Med Oncol. 2010 Dec;27(4):1089-95. doi: 10.1007/s12032-009-9340-7. Epub 2009 Nov 3.
本文引用的文献
1
Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer.对新辅助化疗的反应最能预测胃癌根治性切除术后的生存率。
Ann Surg. 1999 Mar;229(3):303-8. doi: 10.1097/00000658-199903000-00001.
2
Detection of response to chemotherapy using positron emission tomography in patients with oesophageal and gastric cancer.
Br J Surg. 1998 Oct;85(10):1403-6. doi: 10.1046/j.1365-2168.1998.00963.x.
3
Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer.早期术后腹腔内化疗作为可切除胃癌辅助治疗的前瞻性随机试验。
Ann Surg. 1998 Sep;228(3):347-54. doi: 10.1097/00000658-199809000-00007.
4
Changes in tumor marker levels as a predictor of chemotherapeutic effect in patients with gastric carcinoma.
Cancer. 1998 Jul 1;83(1):19-24.
5
Correlation of CT with histopathological findings in patients with gastric and gastro-oesophageal carcinomas following neoadjuvant chemotherapy.
Clin Radiol. 1998 Jun;53(6):422-7. doi: 10.1016/s0009-9260(98)80270-5.
6
Selection of locally advanced gastric carcinoma by preoperative staging laparoscopy.通过术前分期腹腔镜检查选择局部进展期胃癌。
Surg Endosc. 1997 Dec;11(12):1159-62. doi: 10.1007/s004649900560.
7
Breast conservation and prolonged chemotherapy for locally advanced breast cancer: the University of Michigan experience.局部晚期乳腺癌的保乳及延长化疗：密歇根大学的经验
J Clin Oncol. 1997 Aug;15(8):2873-81. doi: 10.1200/JCO.1997.15.8.2873.
8
Systemic chemotherapy for gastric carcinoma followed by postoperative intraperitoneal therapy: a final report.胃癌全身化疗后行术后腹腔内治疗：最终报告
Cancer. 1997 May 1;79(9):1767-75. doi: 10.1002/(sici)1097-0142(19970501)79:9<1767::aid-cncr19>3.0.co;2-w.
9
Laparoscopy in the management of gastric adenocarcinoma.腹腔镜检查在胃腺癌治疗中的应用
Ann Surg. 1997 Mar;225(3):262-7. doi: 10.1097/00000658-199703000-00004.
10
P-glycoprotein as an intermediate end point of drug resistance to neoadjuvant chemotherapy in locally advanced gastric cancer.
Yonsei Med J. 1996 Dec;37(6):397-404. doi: 10.3349/ymj.1996.37.6.397.
Zotero 插件